NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report

Mammary analog secretory carcinoma (MASC) is a newly described carcinoma with a molecular hallmark of ETV6‐NTRK3 fusion that promotes oncogenesis. While MASC histopathology was well‐studied in the literature, clinical behavior remains unstudied. We present a 22‐year‐old man with painless parotid mas...

Descripción completa

Detalles Bibliográficos
Autores principales: AlKaabba, Fahad, Alloghbi, Abdurahman, Deajim, Yazeed, Sukkari, Mohamad W., Khan, Mir Yousufuddin Ali, Sukari, Ammar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445263/
https://www.ncbi.nlm.nih.gov/pubmed/36093449
http://dx.doi.org/10.1002/ccr3.6243
Descripción
Sumario:Mammary analog secretory carcinoma (MASC) is a newly described carcinoma with a molecular hallmark of ETV6‐NTRK3 fusion that promotes oncogenesis. While MASC histopathology was well‐studied in the literature, clinical behavior remains unstudied. We present a 22‐year‐old man with painless parotid mass, which was diagnosed as salivary gland cancer, MASC subtype.

Ejemplares similares